Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927651 · ClinicalTrials.gov registry record · Early Phase 1
ICG to Assess Ovarian Perfusion
A Early Phase 1 study, sponsored by Northwestern University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 54
- Enrollment target
NCT03927651 is a Early Phase 1 study that has completed, run by Northwestern University. The registered enrollment target is 54 participants.
The verdict
NCT03927651, a Early Phase 1 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
To assess the feasibility of using intravenous ICG to characterize the vascular perfusion of ovaries during gynecologic surgery
Interventions
- DRUG ICG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2022-11-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03927651
The ClinicalTrials.gov registry entry for NCT03927651 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ICG is the first listed.
NCT03927651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03927651 about?
NCT03927651 is a clinical study titled "ICG to Assess Ovarian Perfusion". To assess the feasibility of using intravenous ICG to characterize the vascular perfusion of ovaries during gynecologic surgery
What is the current status of trial NCT03927651?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 54 participants. The study started on 2019-06-01. Estimated completion is 2022-11-15.
What interventions are being tested in trial NCT03927651?
The interventions under investigation include: ICG (DRUG).
Who is sponsoring clinical trial NCT03927651?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.